Brief: Hutchmed (China) Says Breakthrough Therapy Designation For Orpathys And Tagrisso Combination

HUTCHMED (China)

12/12/2024 08:35

Dec 12 (Reuters) - HUTCHMED (China) Ltd  0013.HK :
    * BREAKTHROUGH THERAPY DESIGNATION IN CHINA FOR ORPATHYS AND
TAGRISSO COMBINATION IN CERTAIN LUNG CANCER PATIENTS


Further company coverage:  0013.HK 

 ((Reuters.Briefs@thomsonreuters.com;))